8-K: Biotricity Inc. Faces Nasdaq Delisting Threat After Share Price Falls Below $1.00

Biotricity Inc. has received a notification from Nasdaq that its stock price has fallen below the minimum bid price requirement, potentially leading to delisting.

Summary

• Biotricity Inc. received a letter from Nasdaq on July 26, 2024, stating that its closing bid price had been below $1.00 for the past 30 consecutive business days.
• This puts the company in non-compliance with Nasdaq's minimum bid price rule, which requires a share price of at least $1.00.
• The company has been given a 180-day compliance period, until January 22, 2025, to regain compliance.
• To regain compliance, the company's stock price must close at or above $1.00 for a minimum of ten consecutive business days.
• If the company fails to regain compliance within the initial 180-day period, it may be eligible for an additional 180 days if it meets other listing requirements and provides written notice of its intention to cure the deficiency, potentially through a reverse stock split.
• If the company does not regain compliance by the end of the compliance period, it may be delisted from the Nasdaq Capital Market.

Sentiment

Score: 3

Explanation: The document indicates a significant negative event with the potential for delisting, which is a major concern for investors. The company is in a difficult position and needs to take action to regain compliance.

Positives

• The company has been granted a 180-day period to regain compliance with Nasdaq's minimum bid price rule.
• There is a possibility of an additional 180-day compliance period if certain conditions are met.
• The company intends to monitor its stock price and consider options to regain compliance.

Negatives

• The company's stock price has fallen below the minimum bid price of $1.00 for 30 consecutive business days.
• The company is at risk of being delisted from the Nasdaq Capital Market if it does not regain compliance.
• The company may need to consider a reverse stock split to regain compliance.

Risks

• The company faces the risk of delisting from the Nasdaq Capital Market if it cannot increase its stock price above $1.00.
• A reverse stock split, if implemented, could negatively impact the stock price.
• The company's ability to raise capital may be affected by the delisting risk.

Future Outlook

The company intends to monitor its stock price and consider available options to regain compliance with the Bid Price Rule.

Management Comments

• The company intends to monitor the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance with the Bid Price Rule.

Industry Context

This announcement is not specific to the industry, but rather a company-specific issue related to its stock price performance. Other companies in the same sector may face similar challenges if their stock prices fall below minimum listing requirements.

Comparison to Industry Standards

• Many companies on the Nasdaq Capital Market are subject to the same minimum bid price rule.
• Companies that fail to maintain the minimum bid price are at risk of delisting, which is a common issue for smaller or struggling companies.
• A reverse stock split is a common method used by companies to regain compliance with the minimum bid price rule, but it can have negative consequences for shareholders.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company is delisted.
• Employees may be concerned about the company's future.
• The company's reputation may be negatively impacted.

Next Steps

• The company will monitor its stock price.
• The company may consider options to regain compliance, including a reverse stock split.
• The company must achieve a closing bid price of at least $1.00 for ten consecutive business days before January 22, 2025, to avoid delisting.

Key Dates

Keywords

delisting, Nasdaq, minimum bid price, compliance, reverse stock split, stock price, BTCY